Benign biliary strictures: A current comprehensive clinical and imaging review

American Journal of Roentgenology

Volumn 197, Issue 2, 2011, Pages

  Shanbhogue, Alampady Krishna Prasad ^a   Tirumani, Sree Harsha ^b   Prasad, Srinivasa R ^a   Fasih, Najla ^b   McInnes, Matthew ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Bile ducts; Biliary strictures; Biliary tract; Cholangiocarcinoma; MDCT; MRCP

Indexed keywords

ANTIRETROVIRUS AGENT; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; STEROID; URSODEOXYCHOLIC ACID;

BILE DUCT CARCINOMA; BILE DUCT DISEASE; BILE DUCT OBSTRUCTION; BILIARY TRACT BIOPSY; BILIARY TRACT SURGERY; CHOLANGITIS; CHOLECYSTECTOMY; CHRONIC PANCREATITIS; CLINICAL FEATURE; COMMON BILE DUCT STONE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HIV CHOLANGIOPATHY; HUMAN; IATROGENIC DISEASE; IMMUNOGLOBULIN G DEFICIENCY; LIVER TRANSPLANTATION; LYMPHADENOPATHY; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MIRIZZI SYNDROME; MULTIDETECTOR COMPUTED TOMOGRAPHY; PORTAL BILIOPATHY; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; REVIEW; SCLEROSING CHOLANGITIS; SENSITIVITY AND SPECIFICITY;

ANTINEOPLASTIC AGENTS; BILIARY TRACT DISEASES; CONSTRICTION, PATHOLOGIC; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; HIV INFECTIONS; HUMANS; IATROGENIC DISEASE; PANCREATITIS; RISK FACTORS;

EID: 79960726532     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.6002     Document Type: Review

References (89)

1. Judah JR, Draganov PV. Endoscopic therapy of benign biliary strictures. World J Gastroenterol 2007; 13:3531-3539 (Pubitemid 47162260)
2. Moser AJ. Benign biliary strictures. Curr Treat Options Gastroenterol 2001; 4:377-387
3. Bismuth H, Majno PE. Biliary strictures: classification based on the principles of surgical treatment. World J Surg 2001; 25:1241-1244 (Pubitemid 32952567)
4. Warshaw AL, Schapiro RH, Ferrucci JT Jr, Galdabini JJ. Persistent obstructive jaundice, cholangitis, and biliary cirrhosis due to common bile duct stenosis in chronic pancreatitis. Gastroenterology 1976; 70:562-567
5. Tocchi A, Mazzoni G, Liotta G, et al. Management of benign biliary strictures: biliary enteric anastomosis vs endoscopic stenting. Arch Surg 2000; 135:153-157 (Pubitemid 30078466)
6. Blackbourne LH, Earnhardt RC, Sistrom CL, Abbitt P, Jones RS. The sensitivity and role of ultrasound in the evaluation of biliary obstruction. Am Surg 1994; 60:683-690 (Pubitemid 24272515)
7. Neumaier CE, Bertolotto M, Perrone R, Martinoli C, Loria F, Silvestri E. Staging of hilar cholangiocarcinoma with ultrasound. J Clin Ultrasound 1995; 23:173-178
8. Choi SH, Han JK, Lee JM, et al. Differentiating malignant from benign common bile duct stricture with multiphasic helical CT. Radiology 2005; 236:178-183 (Pubitemid 40853310)
9. Govil H, Reddy V, Kluskens L, et al. Brush cytology of the biliary tract: retrospective study of 278 cases with histopathologic correlation. Diagn Cytopathol 2002; 26:273-277 (Pubitemid 34492477)
10. Binkley CE, Eckhauser FE, Colletti LM. Unusual causes of benign biliary strictures with cholangiographic features of cholangiocarcinoma. J Gastrointest Surg 2002; 6:676-681 (Pubitemid 40433485)
11. Choi JY, Lee JM, Lee JY, et al. Navigator-triggered isotropic three-dimensional magnetic resonance cholangiopancreatography in the diagnosis of malignant biliary obstructions: comparison with direct cholangiography. J Magn Reson Imaging 2008; 27:94-101
12. Vitellas KM, Keogan MT, Spritzer CE, Nelson RC. MR cholangiopancreatography of bile and pancreatic duct abnormalities with emphasis on the singleshot fast spin-echo technique. RadioGraphics 2000; 20:939-957; quiz, 1107-1108, 1112
13. Fulcher AS, Turner MA, Capps GW, Zfass AM, Baker KM. Half-Fourier RARE MR cholangiopancreatography: experience in 300 subjects. Radiology 1998; 207:21-32 (Pubitemid 28168663)
14. Lee MG, Lee HJ, Kim MH, et al. Extrahepatic biliary diseases: 3D MR cholangiopancreatography compared with endoscopic retrograde cholangiopancreatography. Radiology 1997; 202:663-669 (Pubitemid 27093434)
15. Kim MJ, Mitchell DG, Ito K, Outwater EK. Biliary dilatation: differentiation of benign from malignant causes - value of adding conventional MR imaging to MR cholangiopancreatography. Radiology 2000; 214:173-181 (Pubitemid 30019887)
16. Soto JA, Alvarez O, Lopera JE, Munera F, Restrepo JC, Correa G. Biliary obstruction: findings at MR cholangiography and cross-sectional MR imaging. RadioGraphics 2000; 20:353-366
17. Park MS, Kim TK, Kim KW, et al. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. Radiology 2004; 233:234-240 (Pubitemid 39280979)
18. Kluge R, Schmidt F, Caca K, et al. Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology 2001; 33:1029-1035 (Pubitemid 32378198)
19. Domagk D, Wessling J, Reimer P, et al. Endoscopic retrograde cholangiopancreatography, intraductal ultrasonography, and magnetic resonance cholangiopancreatography in bile duct strictures: a prospective comparison of imaging diagnostics with histopathological correlation. Am J Gastroenterol 2004; 99:1684-1689 (Pubitemid 39237492)
20. Materne R, Van Beers BE, Gigot JF, et al. Extrahepatic biliary obstruction: magnetic resonance imaging compared with endoscopic ultrasonography. Endoscopy 2000; 32:3-9 (Pubitemid 30071899)
21. DeWitt J, Misra VL, Leblanc JK, McHenry L, Sherman S. EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results. Gastrointest Endosc 2006; 64:325-333 (Pubitemid 44233562)
22. Rosch T, Hofrichter K, Frimberger E, et al. ERCP or EUS for tissue diagnosis of biliary strictures? A prospective comparative study. Gastrointest Endosc 2004; 60:390-396 (Pubitemid 39164248)
23. Eloubeidi MA, Chen VK, Jhala NC, et al. Endoscopic ultrasound-guided fine needle aspiration biopsy of suspected cholangiocarcinoma. Clin Gastroenterol Hepatol 2004; 2:209-213 (Pubitemid 38293307)
24. Martin RF, Rossi RL. Bile duct injuries: spectrum, mechanisms of injury, and their prevention. Surg Clin North Am 1994; 74:781-803; discussion, 805-807
25. Pitt HA, Kaufman SL, Coleman J, White RI, Cameron JL. Benign postoperative biliary strictures: operate or dilate? Ann Surg 1989; 210:417-425; discussion, 426-427
26. MacFadyen BV Jr, Vecchio R, Ricardo AE, Mathis CR. Bile duct injury after laparoscopic cholecystectomy: the United States experience. Surg Endosc 1998; 12:315-321 (Pubitemid 128527424)
27. Roslyn JJ, Binns GS, Hughes EF, Saunders-Kirkwood K, Zinner MJ, Cates JA. Open cholecystectomy: a contemporary analysis of 42,474 patients. Ann Surg 1993; 218:129-137 (Pubitemid 23229138)
28. Barriga J, Thompson R, Shokouh-Amiri H, et al. Biliary strictures after liver transplantation: predictive factors for response to endoscopic management and long-term outcome. Am J Med Sci 2008; 335:439-443
29. Quiroga S, Sebastia MC, Margarit C, Castells L, Boye R, Alvarez-Castells A. Complications of orthotopic liver transplantation: spectrum of findings with helical CT. RadioGraphics 2001; 21:1085-1102 (Pubitemid 33707225)
30. Lerut J, Gordon RD, Iwatsuki S, et al. Biliary tract complications in human orthotopic liver transplantation. Transplantation 1987; 43:47-51 (Pubitemid 17002454)
31. Ito K, Siegelman ES, Stolpen AH, Mitchell DG. MR imaging of complications after liver transplantation. AJR 2000; 175:1145-1149
32. Keogan MT, McDermott VG, Price SK, Low VH, Baillie J. The role of imaging in the diagnosis and management of biliary complications after liver transplantation. AJR 1999; 173:215-219 (Pubitemid 29291119)
33. Lee SY, Ko GY, Gwon DI, et al. Living donor liver transplantation: complications in donors and interventional management. Radiology 2004; 230:443-449 (Pubitemid 38133805)
34. Yoon KH, Ha HK, Kim MH, et al. Biliary stricture caused by blunt abdominal trauma: clinical and radiologic features in five patients. Radiology 1998; 207:737-741 (Pubitemid 28279907)
35. Saad WE. Percutaneous management of postoperative anastomotic biliary strictures. Tech Vasc Interv Radiol 2008; 11:143-153
36. Davids PH, Tanka AK, Rauws EA, et al. Benign biliary strictures: surgery or endoscopy? Ann Surg 1993; 217:237-243 (Pubitemid 23102779)
37. Costamagna G, Familiari P, Tringali A, Mutignani M. Multidisciplinary approach to benign biliary strictures. Curr Treat Options Gastroenterol 2007; 10:90-101 (Pubitemid 46579157)
38. Abdallah AA, Krige JE, Bornman PC. Biliary tract obstruction in chronic pancreatitis. HPB (Oxford) 2007; 9:421-428 (Pubitemid 350215036)
39. Eckhauser FE, Knol JA, Strodel WE, Achem S, Nostrant T. Common bile duct strictures associated with chronic pancreatitis. Am Surg 1983; 49:350-358 (Pubitemid 13076498)
40. Petrozza JA, Dutta SK. The variable appearance of distal common bile duct stenosis in chronic pancreatitis. J Clin Gastroenterol 1985; 7:447-450 (Pubitemid 16248656)
41. Vitale GC, Reed DN Jr, Nguyen CT, Lawhon JC, Larson GM. Endoscopic treatment of distal bile duct stricture from chronic pancreatitis. Surg Endosc 2000; 14:227-231 (Pubitemid 30137147)
42. Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 1998; 33:99-103 (Pubitemid 28114077)
43. Bambha K, Kim WR, Talwalkar J, et al. Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community. Gastroenterology 2003; 125:1364-1369 (Pubitemid 37409756)
44. Escorsell A, Parés A, Rodés J, Solís-Herruzo JA, Miras M, de la Morena E. Epidemiology of primary sclerosing cholangitis in Spain: Spanish Association for the Study of the Liver. J Hepatol 1994; 21:787-791 (Pubitemid 24374145)
45. Chapman RW. The colon and PSC: new liver, new danger? Gut 1998; 43:595-596 (Pubitemid 28520085)
46. Saarinen S, Olerup O, Broome U. Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis. Am J Gastroenterol 2000; 95:3195-3199
47. Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med 1995; 332:924-933
48. Krieger J, Seaman WB, Porter MR. The roentgenologic appearance of sclerosing cholangitis. Radiology 1970; 95:369-375
49. Karlsen TH, Schrumpf E, Boberg KM. Update on primary sclerosing cholangitis. Dig Liver Dis 2010; 42:390-400
50. Baluyut AR, Sherman S, Lehman GA, Hoen H, Chalasani N. Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis. Gastrointest Endosc 2001; 53:308-312 (Pubitemid 32207314)
51. Bader TR, Beavers KL, Semelka RC. MR imaging features of primary sclerosing cholangitis: patterns of cirrhosis in relationship to clinical severity of disease. Radiology 2003; 226:675-685 (Pubitemid 36259141)
52. Dodd GD 3rd, Baron RL, Oliver JH 3rd, Federle MP. End-stage primary sclerosing cholangitis: CT findings of hepatic morphology in 36 patients. Radiology 1999; 211:357-362 (Pubitemid 29206801)
53. Fulcher AS, Turner MA, Franklin KJ, et al. Primary sclerosing cholangitis: evaluation with MR cholangiography - a case-control study. Radiology 2000; 215:71-80 (Pubitemid 30190513)
54. Miros M, Kerlin P, Walker N, Harper J, Lynch S, Strong R. Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis before transplantation. Gut 1991; 32:1369-1373
55. Naitoh I, Nakazawa T, Ohara H, et al. Clinical significance of extrapancreatic lesions in autoimmune pancreatitis. Pancreas 2010; 39:e1-e5
56. Nishimori I, Tamakoshi A, Otsuki M. Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in 2002. J Gastroenterol 2007; 42(suppl 18):6-8 (Pubitemid 46863930)
57. Kamisawa T, Takuma K, Egawa N, Tsuruta K, Sasaki T. Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol 2010; 7:401-409
58. Sahani DV, Kalva SP, Farrell J, et al. Autoimmune pancreatitis: imaging features. Radiology 2004; 233:345-352 (Pubitemid 39423790)
59. Carmona RH, Crass RA, Lim RC Jr, Trunkey DD. Oriental cholangitis. Am J Surg 1984; 148:117-124 (Pubitemid 14090214)
60. Sullivan WG, Koep LJ. Common bile duct obstruction and cholangiohepatitis in clonorchiasis. JAMA 1980; 243:2060-2061 (Pubitemid 10107430)
61. Tabata M, Nakayama F. Bacteria and gallstones: etiological significance. Dig Dis Sci 1981; 26:218-224
62. Harris HW, Kumwenda ZL, Sheen-Chen SM, Shah A, Schecter WP. Recurrent pyogenic cholangitis. Am J Surg 1998; 176:34-37 (Pubitemid 28340953)
63. Jain M, Agarwal A. MRCP findings in recurrent pyogenic cholangitis. Eur J Radiol 2008; 66:79-83 (Pubitemid 351434518)
64. Lim JH. Oriental cholangiohepatitis: pathologic, clinical, and radiologic features. AJR 1991; 157:1-8
65. Sheen-Chen SM, Chou FF, Lee CM, Cheng YF, Lee TY. The management of complicated hepatolithiasis with intrahepatic biliary stricture by the combination of T-tube tract dilation and endoscopic electrohydraulic lithotripsy. Gastrointest Endosc 1993; 39:168-171
66. Wilcox CM, Monkemuller KE. Hepatobiliary diseases in patients with AIDS: focus on AIDS cholangiopathy and gallbladder disease. Dig Dis 1998; 16:205-213 (Pubitemid 128531134)
67. Yusuf TE, Baron TH. AIDS cholangiopathy. Curr Treat Options Gastroenterol 2004; 7:111-117 (Pubitemid 38906957)
68. Da Silva F, Boudghene F, Lecomte I, Delage Y, Grange JD, Bigot JM. Sonography in AIDS-related cholangitis: prevalence and cause of an echogenic nodule in the distal end of the common bile duct. AJR 1993; 160:1205-1207 (Pubitemid 23165534)
69. Cello JP. Acquired immunodeficiency syndrome cholangiopathy: spectrum of disease. Am J Med 1989; 86:539-546 (Pubitemid 19121252)
70. Bilgin M, Balci NC, Erdogan A, Momtahen AJ, Alkaade S, Rau WS. Hepatobiliary and pancreatic MRI and MRCP findings in patients with HIV infection. AJR 2008; 191:228-232 (Pubitemid 351955193)
71. Cordero E, López-Cortés LF, Belda O, Villanueva JL, Rodríguez-Hernández MJ, Pachón J. Acquired immunodeficiency syndrome-related cryptosporidial cholangitis: resolution with endobiliary prosthesis insertion. Gastrointest Endosc 2001; 53:534-535 (Pubitemid 33586772)
72. Abdalian R, Heathcote EJ. Sclerosing cholangitis: a focus on secondary causes. Hepatology 2006; 44:1063-1074 (Pubitemid 44748357)
73. Alazmi WM, McHenry L, Watkins JL, et al. Chemotherapy-induced sclerosing cholangitis: longterm response to endoscopic therapy. J Clin Gastroenterol 2006; 40:353-357 (Pubitemid 44309529)
74. Barnett KT, Malafa MP. Complications of hepatic artery infusion: a review of 4580 reported cases. Int J Gastrointest Cancer 2001; 30:147-160 (Pubitemid 36306730)
75. Lorenz M, Müller HH. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol 2000; 18:243-254 (Pubitemid 30056411)
76. Martin RC, Edwards MJ, McMasters KM. Morbidity of adjuvant hepatic arterial infusion pump chemotherapy in the management of colorectal cancer metastatic to the liver. Am J Surg 2004; 188:714-721
77. Shea WJ Jr, Demas BE, Goldberg HI, Hohn DC, Ferrell LD, Kerlan RK. Sclerosing cholangitis associated with hepatic arterial FUDR chemotherapy: radiographic-histologic correlation. AJR 1986; 146:717-721 (Pubitemid 16117261)
78. Sandrasegaran K, Alazmi WM, Tann M, Fogel EL, McHenry L, Lehman GA. Chemotherapy-induced sclerosing cholangitis. Clin Radiol 2006; 61:670-678 (Pubitemid 44028493)
79. Aldrighetti L, Arru M, Ronzoni M, Salvioni M, Villa E, Ferla G. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer. Hepatogastroenterology 2001; 48:1302-1307 (Pubitemid 33010412)
80. Pozniak MA, Babel SG, Trump DL. Complications of hepatic arterial infusion chemotherapy. RadioGraphics 1991; 11:67-79
81. Hazzan D, Golijanin D, Reissman P, Adler SN, Shiloni E. Combined endoscopic and surgical management of Mirizzi syndrome. Surg Endosc 1999; 13:618-620 (Pubitemid 29277237)
82. Csendes A, Diaz JC, Burdiles P, Maluenda F, Nava O. Mirizzi syndrome and cholecystobiliary fistula: a unifying classification. Br J Surg 1989; 76:1139-1143 (Pubitemid 19284435)
83. Johnson LW, Sehon JK, Lee WC, Zibari GB, McDonald JC. Mirizzi's syndrome: experience from a multi-institutional review. Am Surg 2001; 67:11-14 (Pubitemid 33638485)
84. Yun EJ, Choi CS, Yoon DY, et al. Combination of magnetic resonance cholangiopancreatography and computed tomography for preoperative diagnosis of the Mirizzi syndrome. J Comput Assist Tomogr 2009; 33:636-640
85. Dorrance HR, Lingam MK, Hair A, Oien K, O'Dwyer PJ. Acquired abnormalities of the biliary tract from chronic gallstone disease. J Am Coll Surg 1999; 189:269-273 (Pubitemid 29408863)
86. Dhiman RK, Puri P, Chawla Y, et al. Biliary changes in extrahepatic portal venous obstruction: compression by collaterals or ischemic? Gastrointest Endosc 1999; 50:646-652 (Pubitemid 29518046)
87. Chandra R, Kapoor D, Tharakan A, Chaudhary A, Sarin SK. Portal biliopathy. J Gastroenterol Hepatol 2001; 16:1086-1092 (Pubitemid 32990102)
88. Dilawari JB, Chawla YK. Pseudosclerosing cholangitis in extrahepatic portal venous obstruction. Gut 1992; 33:272-276
89. Chevallier P, Denys A, Novellas S, Schmidt S, Schnyder P, Bruneton JN. Magnetic resonance cholangiography features of biliary abnormalities due to cavernous transformation of the portal vein. Clin Imaging 2006; 30:190-194